Andrews Ronald Asbury

Number of records: 34
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
17-Apr-24 4:21 PM
View: 
Transgenomic Inc. (PRPO) 15-Apr-24Grant 3,153$6.66$20,999.0073%
4.31K to 7.46K
26-Oct-23 4:30 PM
View: 
Transgenomic Inc. (PRPO) 24-Oct-23Grant 4,005----1322%
0.3K to 4.31K
14-Sep-23 4:39 PM
View: 
Transgenomic Inc. (PRPO) 12-Sep-23Grant 6,060----100%
0 to 6.06K
09-Dec-22 8:23 PM
View: 
Oncocyte Corp (OCX) 01-Dec-22Option Exercise 250,000----75%
333.21K to 583.21K
18-Aug-22 4:05 PM
View: 
Oncocyte Corp (OCX) 16-Aug-22Private Purchase 40,000$0.96$38,400.0014%
293.21K to 333.21K
17-Mar-22 9:26 PM
View: 
Oncocyte Corp (OCX) 16-Mar-22Private Purchase 50,000$1.28$64,150.0021%
243.21K to 293.21K
02-Jul-21 9:32 PM
View: 
Oncocyte Corp (OCX) 01-Jul-21Payment of Exercise 15,834----(6%)
259.05K to 243.21K
02-Jul-21 9:32 PM
View: 
Oncocyte Corp (OCX) 01-Jul-21Option Exercise 65,000----33%
194.05K to 259.05K
02-Jul-21 1:59 PM
View: 
Oncocyte Corp (OCX) 30-Jun-21Payment of Exercise 25,873----(12%)
219.92K to 194.05K
02-Jul-21 1:59 PM
View: 
Oncocyte Corp (OCX) 07-May-21Option Exercise 106,221----93%
113.7K to 219.92K
22-Mar-21 5:17 PM
View: 
Oncocyte Corp (OCX) 19-Mar-21Market Purchase 11,000$4.79$52,702.1011%
102.7K to 113.7K
< 1%
12-Mar-21 4:35 PM
View: 
Oxford Immunotec Global Plc (OXFD) 08-Mar-21Disposition 4,081$22.00$89,782.00(100%)
4.08K to 0
< 1%
04-Aug-20 6:50 PM
View: 
Oncocyte Corp (OCX) 03-Aug-20Market Purchase 40,000$1.35$53,880.0064%
62.7K to 102.7K
74%
26-Jun-20 4:05 PM
View: 
Oxford Immunotec Global Plc (OXFD) 24-Jun-20Grant 4,081----100%
0 to 4.08K
01-Apr-20 4:05 PM
View: 
Oncocyte Corp (OCX) 31-Mar-20Purchase 18,000$2,372.00$42,696,000.0040%
44.7K to 62.7K
01-Apr-20 4:05 PM
View: 
Oncocyte Corp (OCX) 30-Mar-20Market Purchase 27,216$2.26$61,453.70156%
17.48K to 44.7K
4%
31-Jul-18 9:39 PM
View: 
Oncocyte Corp (OCX) 26-Jul-18Purchase 17,482----100%
0 to 17.48K
04-Feb-14 2:54 PM
View: 
Invitrogen Corp. (LIFE) 03-Feb-14Disposition 7,357$76.13$560,097.00(100%)
7.36K to 0
99%
03-Apr-13 9:19 PM
View: 
Invitrogen Corp. (LIFE) 02-Apr-13Payment of Exercise 1,213$65.75$79,754.80(14%)
8.57K to 7.36K
99%
03-Apr-13 9:19 PM
View: 
Invitrogen Corp. (LIFE) 02-Apr-13Option Exercise 3,067$65.75$201,655.0056%
5.5K to 8.57K
(99%)
05-Feb-13 5:28 PM
View: 
Invitrogen Corp. (LIFE) 01-Feb-13Payment of Exercise 1,399$65.24$91,270.80(20%)
6.9K to 5.5K
99%
05-Feb-13 5:28 PM
View: 
Invitrogen Corp. (LIFE) 01-Feb-13Option Exercise 3,572$65.24$233,037.00107%
3.33K to 6.9K
(99%)
01-May-12 8:22 PM
View: 
Invitrogen Corp. (LIFE) 27-Apr-12Market Purchase 3,330$46.49$154,814.00100%
0 to 3.33K
(99%)
23-Dec-10 2:08 PM
View: 
Clarient, Inc. (CLRT) 22-Dec-10Disposition 500,000$5.00$2,500,000.00(100%)
500.0K to 0
< 1%
21-Dec-10 5:19 PM
View: 
Clarient, Inc. (CLRT) 17-Dec-10Disposition (change in control) 72,500$5.00$362,500.00(13%)
572.5K to 500.0K
(< 1%)
03-Dec-10 7:38 PM
View: 
Cardiac Science Corporation (CSCX) 01-Dec-10Disposition (change in control) 1,000$2.30$2,300.00(100%)
1.0K to 0
< 1%
05-Nov-10 6:07 PM
View: 
Cardiac Science Corporation (CSCX) 05-Nov-10Option Exercise 1,000----100%
0 to 1.0K
09-Jun-10 2:48 PM
View: 
Clarient, Inc. (CLRT) 08-Jun-10Grant 500,000----690%
72.5K to 572.5K
15-Mar-10 3:58 PM
View: 
Clarient, Inc. (CLRT) 12-Mar-10Market Purchase 12,000$2.41$28,920.0020%
60.5K to 72.5K
1%
19-Sep-08 8:23 AM
View: 
Clarient, Inc. (CLRT) 18-Sep-08Market Purchase 7,500$1.93$14,510.2014%
53.0K to 60.5K
30%
08-May-07 8:16 PM
View: 
Clarient, Inc. (CLRT) 07-May-07Market Purchase 5,000$1.92$9,600.0010%
48.0K to 53.0K
31%
16-Nov-05 2:46 PM
View: 
Clarient, Inc. (CLRT) 14-Nov-05Market Purchase 10,000$1.19$11,880.0026%
38.0K to 48.0K
112%
16-Jun-05 7:43 PM
View: 
Clarient, Inc. (CLRT) 10-Jun-05Market Purchase 18,000$1.40$25,250.4090%
20.0K to 38.0K
79%
10-Aug-04 10:00 PM
View: 
Clarient, Inc. (CLRT) 06-Aug-04Market Purchase 20,000$1.15$23,000.00100%
0 to 20.0K
119%